<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02518542</url>
  </required_header>
  <id_info>
    <org_study_id>POETA</org_study_id>
    <nct_id>NCT02518542</nct_id>
  </id_info>
  <brief_title>Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia</brief_title>
  <acronym>POETA</acronym>
  <official_title>Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) as Additional Endoscopic Treatment Options for Achalasia and Other Esophageal Motility Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Achalasia is an esophageal motility disorder, which leads to clinical symptoms such as
      dysphagia, regurgitation, chest pain and consecutive weight loss.

      Although conventional treatment such as laparoscopic Heller myotomy (LHM) and balloon
      dilatation (BD) can provide sufficient symptom relief in many patients, both interventions
      have their individual drawbacks. Additionally, treatment after failed LHM or BD can be
      challenging and in few might even lead to esophagectomy.

      Per oral endoscopic myotomy (POEM) and prolonged dilatation (PRD) are two novel
      endoscopically performed therapeutic options for achalasia and other esophageal motility
      disorders. Both not only appear to provide good results, when performed as initial treatment
      but also might be an excellent option after e.g failed LHM.

      The purpose of this study is to evaluate the long-term efficacy of four different treatment
      options, such as POEM, PRD with stent-fixation, PD and conventional LHM for achalasia in an
      individualized treatment setting.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2027</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Achalasia specific symptoms according to the Eckardt score (0-12)</measure>
    <time_frame>6 mo post-op</time_frame>
    <description>Eckardt score: Weight loss 0kg (0), less than 5kg (1), 5-10 kg (2), more than 10 kg (3); Dysphagia none(0), occasional (1), daily (2), every meal (3); Regurgitation none(0), occasional (1), daily (2), every meal (3); Retrosternal pain none(0), occasional (1), daily (2), every meal (3)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Barium column height (cm) in esophagogram</measure>
    <time_frame>6 mo post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting pressure (mmHg) at the lower esophageal sphincter</measure>
    <time_frame>6 mo post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent migration</measure>
    <time_frame>p.o. day 1</time_frame>
    <description>Analysis: On the first postoperative day a routine esophagogram will be used to evaluate the appropriate location of the esophageal stent. Early distal stent dislocation/migration into the stomach will be registered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of time (min)/24h that the pH is less than 4.0 in pH-metry</measure>
    <time_frame>6 mo post-op</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Esophageal Achalasia</condition>
  <arm_group>
    <arm_group_label>Per oral endoscopic therapy A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Per oral endoscopic myotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Per oral endoscopic therapy B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prolonged dilatation by implantation of large diameter stents.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Per oral endoscopic therapy C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dilatation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic Heller myotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic intervention A</intervention_name>
    <description>POEM: Per oral endoscopic myotomy</description>
    <arm_group_label>Per oral endoscopic therapy A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic intervention B</intervention_name>
    <description>PRD: Prolonged dilatation by temporary implantation of large diameter stent . Stents are additionally attached to the esophageal wall by different technical options.</description>
    <arm_group_label>Per oral endoscopic therapy B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic intervention C</intervention_name>
    <description>Endoscopic balloon dilatation</description>
    <arm_group_label>Per oral endoscopic therapy C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Surgery</intervention_name>
    <description>Laparoscopic Heller myotomy</description>
    <arm_group_label>Laparoscopic surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed diagnosis of achalsia, hypertensive lower esophageal sphincter, nutcracker
             esophagus, or diffuse esophageal spasm

        Exclusion Criteria:

          -  Contraindication for EGD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Department of Surgery, Medical University of Vienna</last_name>
    <phone>+43 1 40400</phone>
    <phone_ext>5621</phone_ext>
    <email>sebastian.schoppmann@meduniwien.ac.at; erwin.rieder@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Surgery, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian F Schoppmann, MD</last_name>
      <phone>+43 1 40400</phone>
      <phone_ext>5621</phone_ext>
      <email>sebastian.schoppmann@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Erwin Rieder, MD</last_name>
      <phone>+43 1 40400</phone>
      <phone_ext>5621</phone_ext>
      <email>erwin.rieder@meduniwien.ac.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2014</study_first_submitted>
  <study_first_submitted_qc>August 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2015</study_first_posted>
  <last_update_submitted>August 7, 2015</last_update_submitted>
  <last_update_submitted_qc>August 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Erwin Rieder</investigator_full_name>
    <investigator_title>Priv. Doz. Dr. Erwin Rieder</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
    <mesh_term>Esophageal Motility Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

